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Abstract In previous studies it was shown that cannabi-
noids (CBs) bearing a phenolic hydroxyl group modify the
thermal properties of lipid bilayers more significantly than
methylated congeners. These distinct differential properties
were attributed to the fact that phenolic hydroxyl groups
constitute an anchoring group in the vicinity of the head-
group, while the methylated analogs are embedded deeper
towards the hydrophobic region of the lipid bilayers. In this
work the thermal effects of synthetic polyphenolic stilbe-
noid analogs and their methylated congeners have been
studied using differential scanning calorimetry (DSC).
Molecular dynamics (MD) simulations have been per-
formed to explain the DSC results. Thus, two of their
phenolic hydroxyl groups orient in the lipid bilayers in
such a way that they anchor in the region of the head-
group. In contrast, their methoxy congeners cannot anchor
effectively and are embedded deeper in the hydrophobic
segment of the lipid bilayers. The MD results explain the
fact that hydroxystilbenoid analogs exert more significant
effects on the pretransition than their methoxy congeners,
especially at low concentrations. To maximize the polar
interactions, the two phenolic hydroxyl groups are local-
ized in the vicinity of the head-group region, directing the
remaining hydroxy group in the hydrophobic region. This
topographical position of stilbenoid analogs forms a mis-
match that explains the significant broadening of the width
of the phase transition and lowering of the main phase-
transition temperature in the lipid bilayers. At high con-
centrations, hydroxy and nonhydroxy analogs appear to
form different domains. The correlation of thermal effects
with antioxidant activity is discussed.
Keywords DPPC  DSC  Molecular dynamics 
Resveratrol analogs  Stilbenes
Introduction
The importance of the role of membranes in antioxidant
activity is well established. Resveratrol is found to be
located in the lipid region of the bilayer close to the double
bonds of polyunsaturated fatty acids, making them suitable
for prevention and control of lipid peroxidation of the
membranes (Fabris et al. 2008).
In the past, we have published a series of papers in
which the role of phenolic hydroxyl group of cannabinoids
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(CBs) has been studied (Mavromoustakos et al. 1991;
1995a, b; 1996a, b; Yang et al. 1992). It is well known that
phenolic hydroxyl groups in the CB family play a pivotal
role in their bioactivity. In the published research work the
thermal and dynamic properties of CB analogs possessing
phenolic hydroxyl group were compared with the corre-
sponding methylated analogs. We found distinct differen-
tial thermal effects, dynamics, and localization in lipid
bilayers of CBs possessing a hydroxyl group, when com-
pared with those lacking such a group. Surprisingly, mol-
ecules possessing a phenolic hydroxyl group affected lipid
bilayers more significantly than the corresponding meth-
ylated analogs. In particular, CB analogs possessing a
phenolic hydroxyl group lowered and broadened the phase-
transition temperature more significantly at identical molar
fractions in comparison with identical molecules differing
only in the methylation of the phenolic hydroxyl group.
X-ray and neutron diffraction studies have shown different
topographical location in lipid bilayers, and solid-state 2H
nuclear magnetic resonance (NMR) showed different ori-
entation. Molecules possessing a phenolic hydroxyl group
are localized in the interface of the lipid bilayers, with the
phenolic hydroxyl group probably hydrogen-bonding either
with the head-group or the glycerol carbonyls. The meth-
ylated analogs locate themselves deeper in the hydrophobic
region since they lack the anchor for the polar region (Guo
et al. 2008; Martel et al. 1993; Mavromoustakos et al.
1991; 1995a, b; 1996a, b; 1998; 1999; 2001; Sarpietro
et al. 2007, Yang et al. 1993).
In this paper, we describe an extension of our work with
synthetic analogs of resveratrol in an attempt to gain more
insight into the role of phenolic hydroxyl groups on the
effects that bioactive molecules have in lipid bilayers. The
aim of this study is twofold: (1) to answer the question of the
generalization of the thermal effects of compounds pos-
sessing phenolic hydroxyl groups, and (2) to examine the
effect of the modification of the phenolic hydroxyl group. To
achieve these objectives, we synthesized several analogs
possessing phenolic hydroxyl groups together with their
methylated congeners. While our work was in progress, a
similar, more limited study appeared in the literature where
only resveratrol, 3,5,40-tri-O-methylresveratrol, and 3,5,40-
tri-O-acetylresveratrol were evaluated (Sarpietro et al.
2007). Of special interest are the results reported for resve-
ratrol and its trimethylated analog: (a) Resveratrol caused
suppression of the pretransition at all molar fractions used,
while with trimethylresveratrol the same effect was
observed for concentrations higher than x = 0.015, indi-
cating that it probably localizes in the nonpolar region of the
lipid bilayers; (b) Increasing the molar fraction of resveratrol
caused a gradual shift towards a lower main phase-transition
temperature and broadening of the phase transition, indi-
cating a decrease of the cooperativity of the main transition
and the induction of disorder on the structural lipid; resve-
ratrol caused stronger lowering of the phase-transition
temperature than trimethylresveratrol, but the latter exerted
stronger broadening of the width of the phase transition than
the former at x C 0.15; (c) Phase separation was observed
for resveratrol at x = 0.09, while trimethylresveratrol did
not show a well-defined phase separation; resveratrol was
reported to form concentration-rich and concentration-poor
domains; (d) Partition studies showed a high percentage of
the two molecules in lipid bilayers (90% for resveratrol and
99.16% for the trimethylated analog); (e) Kinetic studies
showed that only resveratrol was taken up by the biomem-
brane model, whereas exogenous uptake of the trimethylated
analog was very poor; (f) While the trimethylated analog
showed reduced mobility in aqueous medium when it is
exogenously incorporated, it is effectively taken up by
biomembranes when the aqueous barrier is overcome.
In a recent publication the effects of resveratrol and
picetamol in model bilayers were studied using electron
spin resonance, fluorescence, and differential scanning
calorimetry (DSC). These studies showed preferential
interaction of resveratrol and picetamol with the head-
group region of lipid bilayers (Wesolowska et al. 2009).
In our study, DSC was used for a series of 13 synthetic
stilbenoid molecules (Fig. 1) incorporated in dipalmitoyl-
phosphatidylcholine (DPPC) bilayers at various molar
fractions. These molecules constitute derivatives of resve-
ratrol (compound 1 in Fig. 1) with one or more of the
following characteristics: (1) the ring possessing only one
phenolic hydroxyl group has in the ortho position either
tert-butyl (t-Bu) or 1-ethyl-propyl substituents (-CHEt2);
(2) the coupling of the two aromatic rings is extended by
another olefinic double bond; (3) the phenolic hydroxyl
groups are methylated. Such a series of synthetic analogs
allowed us to study not only the role of phenolic hydroxyl
and methoxy groups but also (1) the ortho substitution
effect of lipophilic segments and (2) the effect of elonga-
tion of the conjugation between the two phenyl rings.
Materials and methods
The phenolic stilbene derivatives were obtained by
demethylation of the corresponding O-methyl analogs
synthesized using the Horner–Wadsworth–Emmons
reaction.
The syntheses of compounds 3, 4, 7, and 8 (Skretas et al.
2007) and 5, 6, and 9–14 have been described (Villalonga-
Barber et al. 2011). Compound 2 (Privat et al. 2002) was
prepared using the procedure described by Villalonga-
Barber et al. (2011) for synthesis of trans-stilbene deriva-
tives, while the synthesis of resveratrol has been described
by Privat et al. (2002).
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Lipophilicity was expressed by the octanol–water par-
tition coefficients, calculated by means of ClopP software
version 4.0 (BioByte, Claremont CA, USA) for Windows.
Structures were introduced in SMILES format. C log P is
based on the Leo–Hansch fragmental system (Leo and
Hoekman 2000). Calculated values of C log P are pre-
sented in Fig. 1, which also includes differences in lipo-
philicity between pairs of compounds.
Differential scanning calorimetry (DSC)
La-DPPC (99 ? %) was purchased from Avanti Polar
Lipids Inc. (Alabaster, AL) and spectroscopic-grade CHCl3
from Sigma–Aldrich (St. Louis, MO). Appropriate amounts
of La-DPPC and the studied synthetic molecules were
diluted in chloroform, mixed and then dried under a stream
of N2, and stored under vacuum overnight. After dispersion
in water (50% w/w), portions of the samples (ca. 5 mg)
were sealed in stainless-steel capsules obtained from
PerkinElmer (Norwalk, CT). Thermal scans were obtained
using a PerkinElmer DSC-7 calorimeter. All samples were
scanned from 10C to 60C until identical thermograms
were obtained, using scanning rate of 2.5C/min. The
temperature scale of the calorimeter was calibrated using
indium (Tm = 156.6C) and DPPC bilayers (Tm = 41.2C).
The following diagnostic parameters in the observed
endothermic events were recorded during the phase tran-
sition and are used for the study of drug–membrane
interactions: Tm (maximum of the temperature peak), Tonset
(starting temperature of the phase transition), and Tm1/2
(full-width at half-maximum of the phase transition). The
area under the peak represents the enthalpy change during
the transition (DH).
A baseline for an empty pan as a reference and a sample
containing double-distilled water was run for the temper-
ature range of 10–60C. For a given temperature range, the
background obtained using the double-distilled water as a
reference was subtracted from the thermal scans of the
samples containing lipid bilayers with or without drug.
DH and Tm values for the pre- and main phase transitions
for DPPC bilayers were compared with those obtained in
the literature (Koynova and Caffrey 1998). Our values were
within those reported in the review (Tm 34.4 ± 2.5 and
41.3 ± 1.8; DH 1.3 ± 1.0 and 8.2 ± 1.4 kcal/mol). Mean
values of three identical scans are tabulated.
The drug concentrations used in the preparations were
x = 0.01 (99% molar ratio of phospholipid, 1% molar ratio
of drug), x = 0.05, x = 0.10, and x = 0.20.
Molecular dynamics (MD) simulations
The DPPC lipid bilayer for the MD simulations was
adopted from Dr. M. Karttunen’s webpage (Patra et al.
2004): 128 DPPC lipids and 3,655 water molecules after
100 ns; (Kandt et al. 2007; Patra et al. 2003). The MD
simulations were performed using the GROMACS 3.3.1
software package (Lindhal et al. 2001) using the GRO-
MOS96 force field (Van Gunsteren et al. 1996). Two rep-
resentative compounds were used: compounds 2 and 14.
Simulations were performed for different concentrations of
compounds in the DPPC lipid bilayers using only one
representative compound (either compound 2 or compound
14) and six molecules (six molecules of compound 2 or six
molecules for compound 14); for the MD simulations of
high drug concentrations, half of them were used in one
DPPC layer and the others were used in another layer.
Ligands were merged to the lipid bilayers as discussed in
the ‘‘Results and discussion’’ section. Lipids clashing with
the ligands were removed from the simulation. For exam-
ple, 88 DPPC lipids and 3,655 water molecules were used
for the MD simulations of high drug concentration at
DPPC. Simulations were run in the isobaric-isothermal
Fig. 1 Compounds used in the study, calculated C log P values, and
the differences in lipophilicity between pairs of compounds
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(NPT) ensemble at 300 K and 1 bar with periodic boundary
conditions. During equilibration, the Berendsen barostat
and thermostat algorithms (Berendsen et al. 1984) were
applied. Electrostatic interactions were calculated using the
particle mesh Ewald method (Essmann et al. 1995). Cutoff
distances for the calculation of Coulomb and van der Waals
interactions were 10 and 14 A˚, respectively. Prior to the
dynamics simulation, energy minimization was applied to
the full system without constraints using a steepest-descent
integrator for 2,000 steps with initial step size of 0.01 A˚
[minimization tolerance set to 1,000 kJ/(mol.nm)]. The
system was then equilibrated by 250 ps (for high drug
concentrations at the lipid bilayer simulations this value
was set to 0.5 ns) simulation with time step of 2 fs; sub-
sequently, a 2.5 ns (for high drug concentrations at the
lipid bilayer simulations this value was set to 3.0 ns)
simulation was performed at 300 K and 1 bar with time
step of 2 fs using Berendsen thermostat and Parrinello-
Rahman barostat algorithms (Parrinello and Rahman
1981). All bonds were constrained using the LINCS algo-
rithm (Hess et al. 1997).
Results and discussion
As a first set of compounds for comparison, we used res-
veratrol (1) and its trimethylated analog (2, Fig. 2). Our
results in DPPC bilayers resembled those reported with
DMPC bilayers by Sarpietro et al. In particular, at
x = 0.01, resveratrol almost suppressed the pretransition
while the trimethylated analog exerted a less pronounced
effect. At higher concentrations, both molecules caused
suppression of the pretransition temperature. Resveratrol
caused more effective lowering of the main phase transi-
tion than its trimethylated analog, while the latter at higher
molar fractions caused more significant broadening. Pre-
transition suppression is frequently observed when a drug
molecule is incorporated in lipid bilayers (Kyrikou et al.
2004a, b; Mavromoustakos et al. 1997; Zoumpoulakis
et al. 2003). This is attributed to perturbation of the head-
group. The presence of the drug molecule affects the
conformational properties of the head-group in phosphati-
dylcholine bilayers. The relationship of the head-group
structures with the pretransition has already been reported
in the literature; for example, dipalmitoylphosphatidyl
ethanolamine (DPPE) bilayers contain ethanolamine
instead of choline as a head-group and do not show pre-
transition in their thermal scans (Houslay and Stanley
1982). Phase separation for the two compounds such as that
reported with DMPC bilayers was not obvious. The
trimethylated analog showed identical DH at x = 0.01 and
lower DH at higher concentrations (Table 1). Comparison
of the results with those obtained using CB analogs show
that a generalization for the two different classes cannot be
Fig. 2 Differential scanning
calorimetry thermograms of
DPPC, DPPC ? 1, and
DPPC ? 2 at x = 0.01,
x = 0.05, x = 0.10, and
x = 0.20 using scanning rate of
2.5C/min
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Table 1 Thermodynamic parameters Tonset, Tm, Tm1/2, and DH for the differential scanning calorimetry scans
Conc. Tonset Tm Tm1/2 DH (kcal/mol)
DPPC 32.6 40.2 34.7 41.2 2.0 1.2 1.09 8.18
1 ? x = 0.01 27.4 39.8 31.1 40.7 4.1 1.1 0.61 8.03
? x = 0.05 – 39.6 – 41.7 – 2.3 – 7.76
? x = 0.1 – 36.1 – 38.3 – 2.3 – 8.27
? x = 0.2 – 34.4 – 36.0 – 2.4 – 8.88
2 ? x = 0.01 31.0 39.5 33.7 40.3 2.4 1.3 – 7.83
? x = 0.05 – 37.8 – 40.0 – 2.1 – 7.00
? x = 0.1 – 35.1 – 37.6 – 2.5 – 5.95
? x = 0.2 – 31.2 – 35.7 – 4.4 – 6.80
3 ? x = 0.01 – 39.4 – 40.5 – 1.4 – 8.18
? x = 0.05 – 38.4 – 40.0 – 1.5 – 7.9
? x = 0.1 – 35.0 – 37.8 – 2.55 – 7.57
? x = 0.2 – 29.0 – 30.4 – 2.95 – 8.01
4 ? x = 0.01 29.7 39.5 32.9 40.9 3.65 1.48 0.63 7.94
? x = 0.05 – 37.0 – 40.4 – 1.9 – 7.09
? x = 0.1 – 33.1 – 39.0 – 4.0 – 7.87
? x = 0.2 – 28.0 – 34.5 – 7.2 – 7.94
5 ? x = 0.01 – 39.8 – 41.2 – 1.45 – 7.92
? x = 0.05 – 38.3 – 40.0 – 1.85 – 7.87
? x = 0.1 – 35.2 – 38.2 – 3.19 – 8.01
? x = 0.2 – 26.8 – 29.8 – 6.25 – 8.15
6 ? x = 0.01 29.1 39.7 32.2 41.0 3.6 1.25 0.39 7.8
? x = 0.05 – 38.2 – 40.5 – 2.1 – 8.01
? x = 0.1 24.3 34.7 24.7 38.6 2.85 4.2 0.05 8.29
? x = 0.2 25.3 32.8 26.5 37.0 2.75 4.65 0.51 7.92
7 ? x = 0.01 – 40.0 – 40.9 – 1.23 – 7.92
? x = 0.05 – 39.0 – 39.3 – 1.33 – 7.99
? x = 0.1 – 36.5 – 38.5 – 1.85 – 7.67
? x = 0.2 – 33.7 – 35.5 – 2.0 – 9.17
8 ? x = 0.01 31.4 40.0 34.1 41.2 2.26 1.4 1.02 8.20
? x = 0.05 28.1 38.4 30.9 39.7 3.1 1.26 0.67 7.67
? x = 0.1 – 37.4 – 39.0 – 1.65 – 6.71
? x = 0.2 – 36.6 – 38.8 – 2.48 – 6.83
9 ? x = 0.01 – 40.0 – 41.0 5.0 1.7 – 7.97
? x = 0.05 – 38.3 – 40.0 – 1.6 – 7.74
? x = 0.1 – 34.4 – 38.0 – 3.8 – 8.25
? x = 0.2 – 24.2 – 27.0 – 5.2 – 8.53
10 ? x = 0.01 29.2 39.6 32.9 40.8 5.2 1.25 0.68 7.87
? x = 0.05 – 38.4 – 40.0 – 1.7 – 7.48
? x = 0.1 – 36.2 – 39.6 – 3.13 – 7.52
? x = 0.2 – 31.6 – 36.3 – 4.88 – 5.71
11 ? x = 0.01 – 39.6 – 40.9 – 1.25 – 8.29
? x = 0.05 – 39.0 – 40.4 – 1.45 – 8.03
? x = 0.1 – 33.7 – 37.8 – 4.5 – 8.6
? x = 0.2 – 23.7 – 25.6 – 9.4 – 8.71
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achieved. The thermal scans of lipid bilayers containing
CB analogs possessing a phenolic hydroxyl group, espe-
cially at high concentrations, contain very broad multi-
component peaks, whereas this is not observed with
resveratrol and its derivatives. The methylated CB analogs
also show lesser thermal effects compared with the trime-
thylated stilbenoid analogs, especially at high concentra-
tions. However, the general trend is the same. Both CB and
stilbenoid analogs suppress the pretransition temperature at
low concentrations, lower the phase-transition temperature,
and significantly broaden the phase transition in a con-
centration-dependent manner. At high concentrations,
‘‘domains’’ are observed, indicating uneven distribution of
the molecules in the lipid bilayers.
These observations are significant because it appears
that DSC scans are very sensitive not only to the presence
of a phenolic hydroxyl group or its methylated derivative
but to other structural details as well. This fact urged us to
examine more synthetic analogs and consider the modifi-
cation of their thermal effects.
The second set of stilbenoid analogs for comparison
(3 and 4, Fig. 3) contains a t-Bu group (X substituent) ortho
to the -OH or -OCH3 group. At x = 0.01 the hydroxylated
analog 3 suppresses the pretransition and 4 affects it sig-
nificantly by broadening it. At higher concentrations, both
exert suppression of the pretransition. At x = 0.01, both
molecules affect the width of the pretransition more in
comparison with the nonalkylated compounds 1/2 couple.
At x C 0.10, the hydroxyl-bearing analog shows phase
separation as the transition peak clearly indicates at least
two components. As with compounds 1 and 2, the
hydroxylated analog causes more effective lowering of the
phase transition and, at concentrations of x C 0.10, less
broadening. In comparison with 1 and 2 the broadening
and lowering of the phase-transition temperature is more
prominent. This is attributed to the t-Bu group. Such a
bulky group may compel the monohydroxylated ring to
locate away from the polar region. The phenolic hydroxyl
group is forced to be situated in a less favorable, more
lipophilic environment where the t-Bu group has more
affinity, and this mismatch causes phase separation. Above
a critical concentration, the molecules are probably posi-
tioned into two different and distinct localizations in lipid
bilayers. Different domains are therefore formed due to
the different localization of the drug molecules in the lipid
bilayers. Thus, the gradual increase of the width in the
phase transition is attributed to two factors: (i) increase of
incorporation; and (ii) effective mismatch. This hypothe-
sis, as we will discuss later, is strengthened by the MD
experiments and C log P calculations.
In the third set of two compounds (5 and 6, Fig. 4) the
t-Bu group is replaced by a 1-ethyl-propyl substituent. As
expected, the thermal profiles for 5 and 6 are very similar
to those observed for 3 and 4. However, it should not
escape our notice that there are significant differences
between the two sets of compounds 3/4 and 5/6 at the high
concentration of x = 0.20. Generally, thermal scans at high
concentrations are very sensitive to experimental condi-
tions, and the formation of domains is not fully reproduc-
ible (Mavromoustakos et al. 1995b). Similar conclusions
have been obtained for the other four pair of analogs 7/8,
9/10, 11/12, and 13/14 (see Fig. SF1–SF4 in the Supple-
mentary Material).
It has been previously reported that the proper confor-
mation, orientation, and location of a drug molecule in the
membrane are critical for it to reach its site of action and
interact productively with that site (Fotakis et al. 2010;
Kyrikou et al. 2004a, b; Martel et al. 1993; Mavromou-
stakos et al. 1994; 1995a, b, 1997; Zoumpoulakis et al.
2003). To investigate the orientation of the studied mole-
cules in the DPPC bilayers, MD simulations have been
applied. For this study, two representative compounds are
Table 1 continued
Conc. Tonset Tm Tm1/2 DH (kcal/mol)
12 ? x = 0.01 29.6 39.2 32.5 40.5 3.9 1.2 0.61 7.78
? x = 0.05 – 37.9 – 39.7 – 1.7 – 7.97
? x = 0.1 – 35.3 – 39.1 – 3.3 – 7.76
? x = 0.2 – 34.9 – 38.4 – 3.3 – 7.55
13 ? x = 0.01 28.4 40.1 32.0 40.9 3.5 1.3 0.5 7.9
? x = 0.05 – 38.1 – 39.9 – 1.9 – 7.6
? x = 0.1 – 32.8 – 39.2 – 6.3 – 5.7
? x = 0.2 – 30.5 – 35.9 – 6.0 – 2.7
14 ? x = 0.01 28.8 40.1 32.2 41.3 3.4 1.2 0.5 7.9
? x = 0.05 – 38.1 – 40.1 – 1.8 – 7.6
? x = 0.1 – 34.1 – 37.5 – 5.3 – 6.2
? x = 0.2 – 28.0 – 35.4 – 6.5 – 4.7
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selected for discussion: the methyl analog of resveratrol 2
and compound 14. Studies showed identical results using
two different drug concentrations in the lipid bilayer (either
one molecule or six molecules in the lipid bilayer). The two
molecules were initially placed in an identical position and
orientation (the lipophilic segment of the molecules
approximately parallel to the bilayer normal) in the bilayer
and then subjected to MD (Fig. 5).
Figure 6 shows the radial distribution function (RDF)
between oxygen atoms of ligands and phosphorus atoms of
lipid bilayers. While compound 14 is packed perfectly in
the vicinity of the head-groups of the lipid bilayer (*5 A˚),
compound 2 does not locate in the realm of the head-group
(Figs. 5, 7). The two hydroxyl groups (oxygen numbering
O14 and O16) of compound 14 (Fig. 7b) are not restricted
by any alkyl branching on the compound, and this part of
ligand can reach the polar head-groups of lipid (i.e., blue
and black lines in the RDF plot, Fig. 6b). The red line in
this plot represents the distribution of O15 of ligand 14
with the lipids, where the alkyl substituents restrain its
distribution with the head-groups of the lipid bilayer (it is
observed that the red line does not have a sharp peak,
showing no pair distribution). The RDF plot for compound
2 does not have sharp peaks (Fig. 6a). O19 of compound 2
distributes closer to the head-groups of the lipid bilayer
compared with O15 and O17.
MD results show that molecules that possess phenolic
hydroxyl groups orient in the lipid bilayers in an awkward
orientation with their long axis such that the majority of the
hydroxy groups anchor in the realm of the head-group. In
contrast, their methoxy congeners orient with the long axis
perpendicular to the plane of the lipid bilayers. Calculation
of values for the seven pairs of analogs supports this
interpretation. For all pairs used, methylated analogs had
higher C log P (ranging between 0.53 and 0.79) than the
corresponding hydroxyl stilbenoid congeners (Fig. 1).
Such an orientation was also observed for the corre-
sponding CB analogs. These MD results explain the fact
that hydroxylated molecules exert more significant effects
on the pretransition than their methoxy congeners, espe-
cially at low concentrations. This awkward orientation
observed for the hydroxylated molecules maximizes the
Fig. 3 Differential scanning
calorimetry thermograms of
DPPC, DPPC ? 3, and
DPPC ? 4 at x = 0.01,
x = 0.05, x = 0.10, and
x = 0.20 using scanning rate of
2.5C/min
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polar interactions but leaves the remaining hydroxyl group
to be embedded in the hydrophobic region. This mismatch
explains the greater broadening of the width of the phase
transition and lowering of the main phase-transition tem-
perature. At high concentrations, hydroxylated and non-
hydroxylated compounds appear to form different domains.
This is also explained by MD calculations which show
several topographical locations (i.e., distribution in the
upper and lower segments of the lipophilic core) for the
compounds in the lipid bilayers. The different locations
expressed as different domains result in broad multicom-
ponent thermal scans.
MD calculations confirm the DSC experimental obser-
vations. The analogs that contain phenolic hydroxyl groups
affect the pretransition temperature more significantly
because they anchor in the head-group region. In addition,
the distribution results explain the significant broadening
and formation of domains of the two compounds due to the
mismatch of polar and nonpolar interactions.
Experimental data showed that only hydroxylated ana-
logs possess neuroprotective antioxidant activity
(Villalonga-Barber et al. 2011). This neuroprotective
activity was more evident for molecules possessing alkyl
substituents on their aromatic rings, with derivatives with
two alkyl substituents outperforming those with one such
group, presumably as a result of higher stabilization of the
respective aroxyl radical. Interestingly, the most potent
derivatives displayed C log P values in the range 6.3–7.6,
which is higher than that usually seen with most drugs,
likely reflecting the need for increased placement into
plasma and/or mitochondrial membranes to improve
potency. We reasoned that lipophilic antioxidants are likely
to be more capable of reaching sites of reactive oxygen
species (ROS) production inside mitochondria (Villalonga-
Barber et al. 2011). The DSC and MD data can provide a
mechanistic basis in support of this observation, since they
propose a mode of placement of the stilbenoid derivatives
in lipid bilayers that is correlated with the differences in
their neuroprotective potency. Methylated analogs are
embedded deeper in the hydrophobic segment of the lipid
bilayers and cannot exert any action on the polar interface.
Stilbenoid hydroxylated analogs, on the other hand,
Fig. 4 Differential scanning
calorimetry thermograms of
DPPC, DPPC ? 5, and
DPPC ? 6 at x = 0.01,
x = 0.05, x = 0.10, and
x = 0.20 using scanning rate of
2.5C/min
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because they bear phenolic hydroxyl ‘‘anchors’’, are posi-
tioned in the interface of the lipid bilayers. When these
polyphenolic analogs possess alkyl substituents, the mole-
cules are oriented in an awkward way, i.e., with their long
axis almost parallel to the bilayer plane, in order to max-
imize the polar interactions. The molecules still have an
accessible phenolic hydroxyl group in the upper part of the
lipophilic segment. This group may serve to prevent lipid
hyperoxidation when unsaturated lipids are present in the
lipid bilayers. As shown for a-tocopherol in a recent review
article, this is a suitable position to exert its antioxidant
action (Atkinson et al. 2008). Firstly, it communicates with
the polar region and exerts a possible interaction with
ascorbic acid, and secondly, it interacts with unsaturated
parts of the lipids and prevents hyperoxidation. A similar
membrane location and phenolic hydroxyl function has
been also proposed to account for the antioxidant neuro-
protective activity of 17b-estradiol based on rotational-
echo double-resonance NMR studies of interaction of the
hormone and analogs thereof with DPPC phospholipid
multilamellar vesicles (Cegelski et al. 2006). Estradiol is
thought to intercalate into the neuronal plasma and
mitochondrial membranes with its phenolic ring positioned
near the site of lipid peroxidation, thus preventing oxida-
tive stress-induced collapse of ion gradients and mito-
chondrial energy production failure, known to result in
damage of the organelle and cell death (reviewed by
Simpkins et al. 2010).
Conclusions
In this research work, modifications of thermal effects
caused by synthetic polyphenolic stilbenoids and their
methylated congeners on lipid bilayers have been studied
to provide more information concerning the effect of
phenolic hydroxyl groups and their methylated analogs.
Previous studies showed that CBs bearing a phenolic
hydroxyl group modify the thermal properties of lipid
bilayers more significantly than the methoxy analogs, and
these effects were attributed to the fact that, while phenolic
hydroxyl groups anchor in the region of the lipid bilayer
head-group, the methoxy analogs are embedded deeper
towards the hydrophobic region.
Fig. 5 Orientations of trimethylated analog of resveratrol (compound
2) and compound 14 within the bilayer before (t = 0 ns) and after
(t = 2 ns) MD simulations. In addition to initial and final conforma-
tions of compounds at the lipid bilayer environment, superimpositions
of initial and final conformations are also depicted for clarity (d and f).
Top (a–c) and bottom (d–f) figures represent topological changes of
compounds 2 and 14, respectively, at the lipid bilayer
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Although, in general, a similar picture emerges from this
study, some subtle differential thermal effects lead to fur-
ther understanding of the phenolic hydroxyl groups. The
analogs possessing phenolic hydroxyl groups generally
modify the effects of lipid bilayers more significantly, but
this is not as pronounced as with the CBs. In addition, at
high concentrations, both analogs exert similar thermal
effects expressed as broadening of the width of the phase
transition temperature and lowering of the phase transition
and cause of phase separation.
To further generalize our observations on the two clas-
ses of molecules, it appears that, when drug molecules are
forced to act on the interface through membrane pertur-
bation, phenolic hydroxyl groups can serve as anchors to
achieve this purpose. This information could be of benefit
for synthetic chemists who are seeking to design molecules
which act on the interface region of the membranes. An
additional and potentially useful design factor which arises
from this study is that molecules possessing a mismatch of
substituents in the vicinity of lipophilic region are able to
significantly perturb the lipid bilayer.
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